|
| |
valentis burlingame Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Valentis
The ability to produce high-level transgene expression following the... 14th July, 2004, Valentis, Inc, Burlingame, CA 94010, USA. Expert Opin Biol Ther. ...
http://www.bioportfolio.com/biocorporate/10726-Valentis.html...
|
A Stopped-Flow Kinetic Study of the Assembly of Nonviral Gene ...
Plasmid DNA pMB 290 (4.9 kbp, >95% supercoiled) was provided by Valentis ( Burlingame, CA). The PAMAM dendrimers of generations 2, 4, 7, and 9 were a gift
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...
|
Just human nature - Nature Biotechnology
Bennet Weintraub, chief financial officer of Valentis (Burlingame, CA), has already weathered the storm ensuing from a merger, and he has emerged with a ...
http://www.nature.com/nbt/journal/v19/n6s/full/nbt0601supp_B...
|
BioSpace - Valentis, Inc. News, Search Jobs, Events
Valentis, Inc. 863A Mitten Road Burlingame California 94010 U.S.A. ... Valentis, Inc. (VLTS)'s Common Stock to be Quoted on the NASD's Over-The-Counter ...
http://www.biospace.com/company_profile.aspx?CompanyId=51104...
|
People - Nature Biotechnology
Gillian Francis has resigned her position as managing director of PolyMASC Pharmaceuticals, a wholly owned subsidiary of Valentis (Burlingame, CA), ...
http://www.nature.com/nbt/journal/v19/n4/full/nbt0401_386.ht...
|
Systemic protein delivery by muscle-gene transfer is limited by a ...
... construct (AAV-C5/12-OVA), the CMV enhancer/promoter was replaced by the muscle-specific synthetic C5-12 promoter obtained from Valentis (Burlingame, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
HGS targets patent-expiring drugs - Nature Biotechnology
However, Valentis (Burlingame, CA) has already overcome the problem of denaturation arising from the pegylation process, according to CFO Bennet
Weintraub. ...
http://www.nature.com/nbt/journal/v18/n12/full/nbt1200_1238b...
|
Contribution of Hydrophobicity to Thermodynamics of Ligand-DNA ...
Plasmid DNA encoding vascular endothelial growth factor was a kind gift from Valentis (Burlingame, CA). DNA was precipitated with ethanol and 2 M NaCl ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...
|
BioPortfolio - keel pharmaceuticals patents
Valentis (Burlingame, CA) lost a key patent decision in its suit against ALZA .. . Gilead Sciences acquired Triangle Pharmaceutical; Harvard Biosciences . ...
http://www.bioportfolio.com/search/_keel_pharmaceuticals__pa...
|
NIH SMALL BUSINESS INNOVATIVE RESEARCH AWARDS Fiscal Year 1997 Ref ...
TOTAL: $100000 CALIFORNIA, BURLINGAME (ZIP 94010): VALENTIS, INC. Nordstrom, Jeffrey L 5R44NS033069-03 $250875 CONTROLLED GENE THERAPY USING A MOLECULAR ...
http://grants.nih.gov/grants/Funding/sbirsttr97.txt...
|
|
